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• We studied seven patients aged 14 to 40 years who received living-related kidney transplants and had allograft 
survivals of 26 to 29 years. The blood urea and creatinine were either within normal limits or marginally elevated. 
Histopathologic examination showed only mild mesangial expansion, interstitial fibrosis, and arteriosclerosis. Immu-
noperoxidase staining with anti-HLA antibodies or in situ hybridization with a Y chromosome probe showed persistence 
of donor tubular epithelium and vascular endothelium within the graft. Recipient-derived glomerular cells were seen 
in one case, and interstitial lymphocytic infiltrates were seen in all cases. A review of the clinicopathologic data 
available for these cases indicated that both central and peripheral immunologic mechanisms contributed to the 
maintenance of prolonged graft survival. This extended survival was independent of six antigen matching, down-
regulation of donor HLA antigen expression, and ingrowth of host epithelium/endothelium into the allograft. 
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R ENAL transplantation is currently a well-ac-
cepted modality for the treatment of end-stage 
renal disease. Sequential histopathologic exami-
nation of allografts during the first several years 
posttransplant frequently reveals progressive inter-
stitial fibrosis, tubular atrophy, arteriosclerosis, and 
glomerulosclerosis. 1-4 These changes are generically 
referred to as chronic allograft nephropathy and 
are believed to result from the combined interplay 
of multiple factors, such as rejection, drug toxicity, 
hypertension, pyelonephritis. mismatched nephron 
mass, and hemodynamic changes in renal blood 
flow. 5-8 Deterioration of renal function occurs pari 
passu with these changes. The current estimated 
lO-year graft survival is 42%.9 Approximately half 
of these patients do exceptionally well, and several 
original graft survivals exceeding 25 years have been 
reported. 10. II A pathologic evaluation of allografts 
maintaining good renal function for such long pe-
riods has never been reported. It is not known 
whether immunologic tolerance completely pro-
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tects these kidneys from the development of chronic 
allograft nephropathy, or whether initial chronic 
changes subsequently stabilize or perhaps become 
offset by compensatory glomerular enlargement. It 
also is not known whether replacement of donor 
vascular endothelium and tubular epithelium in 
the graft by recipient cells plays a role in maintain-
ing the prolonged graft tolerance observed in these 
cases. To address these questions we performed light 
microscopy, in situ hybridization for the Y chro-
mosome, and immunohistochemistry using anti-
HLA antibodies in seven allografts that have sur-
vived from 26 to 29 years. These seven patients are 
. the subject of this report. 
MATERIALS AND METHODS 
The seven patients whose allografts were sampled were part 
of a larger cohort of 25-year survivors from the early years of 
a kidney transplantation program at the University of Colo-
rado, Denver.1 One of the specimens was obtained at autopsy 
when the recipient of an uncle's kidney died of a stroke. The 
other six were needle biopsy specimens obtained during a re-
cent investigation of chimerism,J2 in which donor- or host-
derived cells were identified in peripheral tissues by their HLA 
specificity or sex chromosome. Because the nature of this in-
vestigation biased the case mix to HLA incompatibility, there 
were no examples of two HLA haplotype matches in this series. 
Five cases had one haplotype mismatch, one case had both 
haplotypes mismatched, and data were not available for the 
remaining case. 
In four cases, the biopsy specimens were snap frozen and 
sectioned at 3 I'm in a cryostat. The sections were fixed in 
cold acetone for 5 minutes, rinsed in phosphate-buffered saline 
(pH 7.4). and blocked with I: to normal goat or horse serum. 
This was followed by a I·hour incubation with undiluted 
mouse anti-human HLA antibodies directed against selected 
donor or host specificities (Table I). Multiple antibody com-
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Table 1. Anti-HLA Antibodies Used in Immunohistochemical Studies 
Case No.1 Case No.2 Case No.3 Case NO.6 
Donor HLA phenotype A2,- 818,27 8w4,6 A1,3 835,44 8w4,6 A3,- 87,- 8w6,- A1,11 857,62 8W4,6 
DR1,4 DQw1,3 DR7,15 DQwl,2 DR4,2 DQwl,3 DR4,7 DQ2,3 
DRW53 
Recipient HLA A2,3 87,27 8w4,6 A3,26 835,- 8W6,- A24,29 844,55 A 1,28 835,57 8W4,6 
phenotype DR1,13 DQw1,- DR1,15 DQw1,- Bw4,6 DR4,7 DR4,15 DQ 1,3 
DQw3,-
Anti-<ionor anbbodies 818 A1,36 8w4, 844 A387,40 All B62 DR 7 DQ2 
Anti-recipient antibodies A2,69' B7,40 A26DR1,10 B7,22/55,27" 835 
Control antibodies A1 ,36 Al ,9,10,11 A2,69 87,22,17 813 A2,69 A2,28 DR1,10 818,51 
• Antibodies directed to specificities shared by donor and recipient. 
binations were used in each case to ensure reliable results. 
The antibodies were a gift from either Genetic Systems (Seattle, 
W A) or One-lambda (Los Angeles, CAl, or were purchased 
from C-six (Mequon, WI). Some antibodies were derived from 
hybridomas obtained through the American Type Culture 
Collection (Rockville, MO). The secondary antibody was per-
oxidase-labeled horse or goat anti-mouse immunoglobulin. 
Color development was done using Biomeda's Peroxidase 
Chromogen Kit (Foster City, CAl. The sections were coun-
terstained with hematoxylin-eosin for routine light microscopy. 
Negative controls consisted of sections incubated with anti-
HLA antibodies of irrelevant specificity, or mouse immuno-
globulin G (IgG) and IgM supernatants. 
Antibodies suitable for discriminating between donor and 
recipient specificities were not available in cases no. 4 and 5. 
In case no. 6 antibodies selected for their donor specificity 
cross-reacted \\ith recipient lymph node and skin, rendering 
interpretation of the immunohistochemical preparations dif-
ficult. Sex mismatch between donor and recipient made it 
possible to circumvent these difficulties in cases no. 4 and 5: 
the donor and host genotypes in these two cases could be 
distinguished using in situ hybridization with a nucleic acid 
probe for the Y chromosome (Oncor, Gaithersberg, MO). The 
procedure used deparaffinized sections of formalin-fixed tissue 
and began with a 40-minute digestion of tissue sections at 
37°C using 6 mg}mL pepsin in 0.12 N HCL. Following three 
I-minute rinses in 2 X sodium chloride sodium citrate buffer 
(ssq and dehydration, 2 ilL biotinylated probe (dissolved 
in 10 ilL Hybrizol VIII [Oncor, Gaithersberg, MOl) were 
applied to each tissue section. Subsequent steps included 
denaturation (at 90.5°C for 12 tninutes), hybridization (at 
37°e overnight), postwash in 2 X SSC-50% formamide (at 
37"e for 15 minutes two times), and washing with 0.1 
X sse (at 37°e for 15 minutes two times) followed by I 
X phosphate buffer detergent (PBD) (at 25°C for 5 minutes). 
Detection of the hybridized target involved sequential in-
cubation with blocking reagent I, fluorescein-labeled avidin, 
1 X PBD, blocking reagent 2. and anti-avidin antibody, and 
then a second round of blocking reagent I and fluorescein-
labeled avidin. following the manufacturer's instructions. 
The preparations were mounted in a propidium iodide an-
tifade solution and examined under the oil immersion lens 
ofa Nikon Optiphot 2 immunofluorescence microscope. The 
Y chromosomes were visualized as a bright green nuclear 
signal against a red background. 
Case no. 7 was a sex-matched recipient who could not be 
analyzed by the Y chromosome probe. Snap-frozen tissue was 
not available for immunohistochemical studies with anti-HLA 
antibodies. 
RESULTS 
The clinical data (Table 2) for patients no. 1, 
2, 3, and 4 have been previously published in a 
Table 2. Clinical Data on Living-Related Kidney Transplant Recipients With Long-term Graft Survival 
Age at Time of 
Case Transplantation Donor Follow-up Allograft AZA PRED 8UN Creatinine 
No. (yr) Sex Donor Age (yr) (yr) Age (yr)' (mg) (mg) (mg/dL) (mg/dL) 
1 16 F Mother 41 29 70 100 0 15 1.2 
2 14 F Mother 36 29 65 75 0 6 0.7 
3 19 M Aunt 58 28 86 0 0 19 1.6 
4 19 F Father 53 28 81 0 7.5 13 0.9 
5 24 M Sister 22 27 49 100 10 21 1.0 
6 18 F Mother 38 28 66 50 7.5 21 1.8 
7 40 M Uncle 46 26 72 0 10 NA 3.0 
Abbreviations: AZA, daily dose of azathioprine; PRED, daily dose of prednisone; BUN, blood urea nitrogen; NA, not 
available . 
• Age of donor at time of transplantation + years of recorded allograft function in recipient. 
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report focusing on the functional immunologic 
parameters and chimeric status of these individ-
uals. 12 All cases recei ved a kidney allograft from 
a living-related donor aged 22 to 58 years. Im-
munosuppression consisted of 0 to 100 mg/d 
azathioprine and 0 to 10 mg/d prednisone main-
tained at the levels indicated in Table 2. Patient 
no . 3 has been offantirejection drugs for the past 
4 months. Renal function, as assessed by blood 
urea nitrogen and creatinine, was either normal 
or marginally compromised. 
The histopathologic alterations seen in these 
cases were in the borderline or mild chronic al-
lograft nephropathy categories, as defined in the 
Banff Working Classification of Kidney Trans-
plant Pathology 4 Representative illustrations are 
provided in Figs I and 2. The interstitial com-
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partment showed sparse to mild lymphocytic in-
filtrates. occasionally arranged in small clusters, 
without significant tubulitis. Mild interstitial fi-
brosis was seen in cases no. 4 and 7 (Fig 2A), but 
in other biopsy specimens, the renal tubules were 
quite closely packed together with little expansion 
of the sampled extracellular matrix (Fig I B). The 
glomeruli showed either minor abnormalities (Fig 
I A) or mild lobular accentuation, increased mes-
angial cellularity, and sclerosis of up to 10% of 
the total glomeruli (Fig 2A). Peritubular capil-
laries. interstitial venules, and arterioles were 
without significant pathologic change. The 
arcuate-sized vessels, when sampled, usually 
showed mild intimal thickening (Fig 28). Elec-
tron microscopy could be performed in case no. 
5. The subendothelial zone was mildly expanded 
Fig 1. Morphologic alter-
ations observed in a needle 
biopsy of the renal allograft in 
case no. 5. (A) The glomerulus 
is essentially unremarkable. 
(Magnification x200.) (8) 
Minimal interstitial fibrosis 
was noted. (Magnification 
X200.) (e) Electron micros-
copy showed a finely granular 
electron-lucent material de-
posited, at a subendothelial 
location, within the glomerular 
basement membranes. (Mag-
nification x5,400.) 
I' 
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Fig 2. Case no. 7 showed more pronounced histopathologic changes than those illustrated in Fig 1. (A) The glomeruli 
showed an accentuation of the lobular pattern and a segmental increase in the mesangial cellularity. The degree of 
interstitial fibrosis was greater than that observed in case no. 5. (Magnification x200.) (8) The arteries showed fibrous 
thickening of the intimal layer. (Magnification X100.) 
by a granular electron lucent material consistent 
with early transplant glomerulopathy (Fig IC). 
Immunohistochemical studies demonstrated 
the mononuclear ceUs infiltrating the interstitium 
to mark for recipient HLA antigens (Fig 3A). The 
endothelial lining of the peri tubular and glomer-
ular capillaries reacted strongly with anti-HLA 
antibodies of donor specificity (Fig 4). The tu-
bular epithelium did not convincingly stain with 
any of the HLA antibodies tested, but hybridized 
with the Y sex chromosome probe. The Y chro-
mosome was also demonstrable in the glomeruli 
and vascular endothelium . In case no. I the glo-
meruli contained numerous cells bearing recip-
ient HLA antigens. Some of these cells seemed 
to line the glomerular capillary tufts while others 
appeared to be mesangial in location (Fig 3B). 
DISCUSSION 
The cases reported here have some of the long-
est graft survivals ever documented in the history 
of kidney transplantation." All patients except 
no. 7 were younger than 25 years at the time of 
transplantation. The mildness of the histopath-
ologic changes seen is remarkable; the chronol-
ogic age of the allografts at last biopsy was 49 to 
86 years (Table 2), and one might have expected 
more prominent age-related glomerulosclerosis, 
interstitial fibrosis, and arteriosclerosis in these 
tissues. The mild glomerular alterations observed 
are similar to those reported in these and other 
well-functioning grafts biopsied 7 to 27 months 
posttransplant.' It is possible that senile changes 
in the kidney, instead of being preprogrammed 
within the organ itself, occur concomitantly with 
generalized metabolic changes in the individual 
as a whole. This would explain our observation 
that older kidneys transplanted into younger in-
divid uals involuted at a rate apparently deter-
mined by the age of the recipient. It must, how-
ever, be pointed out that the rate of progression 
of age-related changes varies considerably from 
individual to individual. Definitive conclusions 
on the mechanisms of renal allograft aging should 
await prospective studies based on a large series 
of patients not specifically selected for prolonged 
graft survival. 
Our experience illustrates that continuous 
azathioprine administration for up to 29 years 
does not in itselflead to any morphologic change 
attributable to the drug. The relative resistance 
of the kidney to clinically significant azathioprine 
toxicity is well known, but actual histopathologic 
examination of allografts maintained on this drug 
for such a prolonged period has not been previ-
ously reported. Azathioprine has only occasion-
ally been implicated in interstitial nephritis.'3 In 
contrast, the long-term administration of cyclo-
sporine (which was not used in any of these pa-
tients) results in interstitial fibrosis and arteriolar 
hyalinosis even if plasma drug levels are main-
tained in a therapeutically acceptable range. 5.6 
The specific mechanisms associated with the 
prolonged graft survival observed in this study 
are not clear. Six-antigen HLA matching was not 
achieved in any of the donor-recipient pairs. 
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Fig 3. (A) Demonstration of recipient·specific HLA A3 antigen expression by the interstitial mononuclear cells in 
case no. 1. (Magnification X200.) (8) This patient was unusual in that some cells with the recipient phenotype had 
also infiltrated the glomeruli. (Magnification x 200.) 
Downregulation of endothelial class I antigen 
expression is also excluded as a significant mech-
anism by the data presented: all biopsy specimens 
examined showed strong staining with the ap-
propriate donor-specific antibodies. In the past, 
replacement of donor vascular endothelium and 
tubular epithelium by recipient cells was concep-
tualized as a possible mechanism of tolerance. 
Studies seeking to test this hypothesis docu-
mented partial replacement in a small percentage 
of cases, but the clinical follow-up was relatively 
short. 14. 16 The patients reported here, who had a 
much longer period of observation, confirm that 
graft tolerance is not predicated on renal cell 
turnover occurring after transplantation. The 
glomeruli in one case did show endothelial/mes-
angial cells of recipient origin, but the bulk of 
the vascular and renal tubular epithelium re-
tained donor phenotype. The limited replace-
ment observed probably followed injury to the 
original donor cells during an episode of acute 
rejection. Seeding of the allograft glomeruli by 
recipient cells could have been mediated by 
circulating mononuclear/endothelial progenitor 
cells or by migration of recipient cells across the 
surgical anastomosis sites. The former mecha-
nism is favored after heart transplantation, since 
areas of recipient mediated re-endothelialization 
tend to be close to previous biopsy sites.17 Partial 
replacement of allograft coronary arteries by re-
cipient myointimal cells also has been reported. IS 
Influx of scattered recipient lymphocytes into 
the graft interstitium was seen in all cases studied. 
The absence of associated tubulitis or vascular 
Fig 4. Needle biopsy of the allograft kidney in case no. 1 stained wiih the anti-HLA A2,69 antibody. Cells in the 
glomeruli (A) as well as the vascular endothelium (8) retained donor specificity 29 years after transplantation. (Mag-
nification X200.) 
RENAL ALLOGRAFT SURVIVAL OF 26 TO 29 YEARS 
injury may be due to a variety of modulating 
influences, such as effector cell blockade, sup-
pressor cells, or antibody-mediated tolerance. 19 
Concomitantly with the migration of recipient 
lymphocytes into the allograft, small numbers of 
donor-derived lymphocytes could be detected in 
recipient lymph nodes and skin of several cases. 12 
The importance of the development of such a 
chimeric state in ensuring prolonged graft sur-
vival is reinforced by parallel observations made 
by us in liver and small intestine transplant re-
cipients.20 The actual mechanism by which this 
low-level chimerism exerts its effects is currently 
unknown. Mutual engagement, activation, and 
ultimately clonal silencing of the immunocytes 
of both parties seems to occur. Mixed lymphocyte 
reactivity assays between donor peripheral blood 
lymphocytes (stimulator cells) and the corre-
sponding recipient cells (responder cells) are de-
pressed in long-term survivors of kidney trans-
plantation. l :! Furthermore, donor cells in these 
cases fail to generate cytotoxic effector cells when 
cultured with host lymphocytes in vitro. Thus, 
there is evidence that prolonged graft survival af-
ter solid organ transplantation is the result of to-
lerogenic mechanisms at both peripheral (intra-
graft) and central (lymph node, peripheral blood) 
levels. 
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